Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA

Journal of Clinical Oncology

Volumn 17, Issue 7, 1999, Pages 2015-2019

  Zach, Otto ^a   Kasparu, Hedwig ^a   Krieger, Otto ^a   Hehenwarter, Wolfgang ^a   Girschikofsky, Michael ^a   Lutz, Dieter ^a  

^a ELISABETHINEN HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARCINOEMBRYONIC ANTIGEN; ESTROGEN RECEPTOR; MAMMAGLOBIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD; BREAST CANCER; CANCER CELL; CANCER STAGING; CARCINOMA; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032983945     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.7.2015     Document Type: Article

References (25)

1. Frost P, Levin B: Clinical implications of metastatic process. Lancet 339:1458-1461, 1992
2. Ghossein RA, Juan R: Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78:10-16, 1996
3. Neumaier M, Gerhard M, Wagener C: Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 159:43-47, 1995
4. Gerhard M, Juhl H, Kalthoff H, et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12:725-729, 1994
5. Mori M, Mimori K, Ueo H, et al: Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease. Int J Cancer 68:739-743, 1996
6. Hildebrandt M, Mapara MY, Korner IJ, et al: Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: A sensitive method for monitoring purging efficiency. Exp Hematol 25:57-65, 1997
7. Fields KK, Elfenbein GJ, Trudeau WL, et al: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14:1868-1876, 1996
8. Datta Y, Adams PT, Drobyski WR, et al: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
9. Krüger W, Krzizanowski C, Holweg M, et al: Reverse transcriptase/ polymerase chain reaction detection of cytokeratin 19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122:679-686, 1996
10. Moscinski LC, Trudeau WL, Fields KK, et al: High-sensitive detection of minimal residual breast carcinoma using polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 5:173-180, 1996
11. Krismann M, Todt B, Schroder J, et al: Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for the detection of hematogenous lung cancer dissemination. J Clin Oncol 13:2769-2775, 1995
12. Mapara MY, Körner IJ, Hildebrandt M, et al: Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 89:337-344, 1997
13. Zippelius A, Kufer P, Honold MW, et al: Limitations of reverse-transcriptase polymerase chain reaction analyses for detectionof micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701-2708; 1997
14. Lopez-Guerrero JA, Bolufer-Gilabert P, Sanz-Alonso M, et al: Minimal illegitimate levels of cytokeratin K19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR). Clin Chim Acta 263:105-116, 1997
15. Bostick PJ, Chatterjee S, Chi DD, et al: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632-2640, 1998
16. Watson MA, Fleming TP: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56:860-865, 1996
17. Watson MA, Darrow C, Zimonjic DB, et al: Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 16:817-824, 1998
18. Zach O, Krüger WH, Kasparu H, et al: Mammaglobin might become a more useful marker than cytokeratin 19 for the detection of circulating breast cancer cells. Onkologie 20:181, 1997 (suppl 1) (abstr)
19. Raj GV, Moreno JG, Gomella LG: Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82:1419-1442, 1998
20. Yang W, Zukerberg L, Motokura T, et al: Cyclin D1 (Bel-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 145:86-95, 1994
21. Dickson C, Fantl V, Gillett C, et al: Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer Lett 90:43-50, 1995
22. Karlseder J, Zeillinger R, Schneeberger C, et al: Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 9:42-48, 1994
23. Pacilio C, Germano D, Addeo R, et al: Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens. Cancer Res 58:871-876, 1998
24. Peters G, Fantl V, Smith R, et al: Chromosome 11q13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 33:124-135, 1995
25. Zhang YJ, Jiang W, Chen CJ, et al: Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 196:1010-1016, 1993